NCT02158806View on ClinicalTrials.gov

Low Dose Aspirin for Venous Leg Ulcers

PHASE3CompletedINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Venous Leg Ulcer
Interventions
DRUG

Aspirin

150 mg aspirin in capsule form once daily for up to 24 weeks

DRUG

Placebo

Matching placebo capsule containing inert bulking agent

All Listed Sponsors
collaborator

Health Research Council, New Zealand

OTHER

lead

University of Auckland, New Zealand

OTHER

NCT02158806 - Low Dose Aspirin for Venous Leg Ulcers | Biotech Hunter | Biotech Hunter